Nov 22, 2023
The Jersey Weight Loss Clinic (732-756-1237) announces medical weight loss treatments using semaglutide GLP-1 that mimic the natural effects of a hormone produced by the body in response to food intake.

Manasquan, United States - November 22, 2023 /PressCable/ —
Jersey Weight Loss Clinic, serving Monmouth and Ocean counties on the Jersey Shore, now offers semaglutide GLP-1 injections in Middletown. This treatment decreases appetite, increases satiety, and slows down gastric emptying. GLP-1 injections are customized for individuals who struggle with traditional weight loss methods.
More information about medical weight loss injections using semaglutide GLP-1 is available at https://jerseyweightlossclinic.com/medical-weight-loss-injection-clinic-nj
The customized GLP-1 weight loss treatment program serving Middletown is a safe and accessible treatment approved by NJ physicians for weight management. Traditionally used to manage Type 2 Diabetes, Semaglutide was found to be effective for weight loss in individuals without diabetes.
With over 70 million adults considered obese and 99 million overweight, the US faces a health crisis that raises the risk of chronic conditions, including cardiovascular disease, T2D, and certain types of cancer.
Traditional weight loss methods, such as diet and exercise, are widely recommended but may only be effective for some. While these approaches can work for some individuals, factors such as underlying health conditions, genetic predispositions, and lifestyle constraints can make it challenging to achieve sustainable weight loss through traditional methods alone, explains the Jersey Weight Loss Clinic team.
The Monmouth County weight loss center provides customized weight loss programs using semaglutide GLP-1 based on a patient's medical history and goals. GLP-1 helps patients reduce caloric intake and experience weight loss by reducing hunger, slowing digestion, and offering long-term support for weight management even after reaching their desired weight.
The Jersey Weight Loss Clinic reports that patients on a weekly dose of their personalized GLP-1 blend experienced fewer cravings and more consistent energy levels. The weight loss programs are a true game changer in the weight loss industry.
The clinic also reports that Tirzepatide is a newer GLP-1 agonist currently being researched for its weight loss efficacy and promising results in clinical trials.
"At Jersey Weight Loss Clinic, we prioritize individualized medical weight loss services to cater to the specific needs of each patient," said a clinic representative, "Under the guidance of healthcare professionals, patients can benefit from the comprehensive approach offered by semaglutide GLP-1 injections, resulting in improved weight management outcomes."
The Jersey Weight Loss Clinic welcomes Middletown residents to a complimentary, no-obligation consultation to evaluate their suitability for GLP-1 treatments.
Interested parties can find more details at https://jerseyweightlossclinic.com/medical-weight-loss-injection-clinic-nj
Contact Info:
Name: Al Dee
Email: Send Email
Organization: Jersey Weight Loss Clinic
Address: 1913 Atlantic Ave STE 151, Manasquan, NJ 08736, United States
Phone: +1-732-838-5111
Website: https://www.jerseyweightlossclinic.com
Source: PressCable
Release ID: 89114057
Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting [email protected]. Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.
It’s not impossible to spot the characteristics of a brewing financial crisis. We can look to 2008 for clues.
Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.
In Ohio, many voters say their frustration about the increase in electricity and fuel prices and the growth of data centers won’t influence whom they vote for.
President Trump’s novel deal-making is on display in upstate New York, where the administration is funneling Japanese funds into a government-owned chip factory.
A Minnesota group worried that its opposition could expose it to prosecution under the state’s deceptive-practices law. Its lawsuit could have wide implications for limiting speech around elections.
The little-known investment Martin Lewis wants you to understand
Demonstrations are expected to continue this weekend in Paris and other French cities. Some museums and tourist sites will be closed, and visitors should expect a strong police presence.
Kashim Chowdhury denied being dishonest when not telling employers he had other jobs.
Among the stakes in next month’s election is the long-running question of whether tax cuts can shape how people vote.
Pennylane, a French company, has gained market share in its home country by helping accountants work with clients. It’s aiming to expand internationally.
The Swedish automaker plans to cut another 2,500 jobs, joining competitors in offering a gloomy view of the world’s biggest car market.
AI uncovered long-hidden programming flaws, triggering a rare global cyber-security response.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.